Rallybio Corporation (RLYB)
Market Open
11 Sep, 14:04
NASDAQ (NGS) NASDAQ (NGS) Primary $
16. 92
+0.17
+1.0149%
$
88.15M Market Cap
- P/E Ratio
- Div Yield
683 Volume
-1.55 Eps
$ 16.75
Previous Close Investors:
Want to track RLYB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rallybio Corporation (RLYB) Statistics
Valuation metrics
Market Cap 88.15M
Enterprise value -3.03M
Trailing P/E (ttm) 2.13
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 139.04
Price/Book (mrq) 1.02
Enterprise Value/Revenue -4.69
Enterprise Value/EBITDA -0.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.2K
Average volume (90 days) 37.14K
Price summary
52-Week low 3.67
52-Week high 17.57
Beta -
50-Day moving average 16.16
200-Day moving average 10.88
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:8
Last split Date 6 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 70.51%
Operating margin -36.72%
Operational effectiveness
Return on assets 0.46%
Return on equity 0.69%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 7.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 16.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 27.26%
Book value per share (mrq) 16.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
